As a clonally propagated crop, cassava breeders currently have adopted a four-stage evaluation strategy in addition to the crossing block stage and the seedling nursery stage where planting material ...
Cassava Sciences (NASDAQ:SAVA) crashed nearly 84% following a late-stage trial setback for its lead asset, simufilam, leaving SAVA investors wondering what’s in store for the once-high-flying ...
a consultant for Cassava and associate medical professor at City University of New York’s Medical School, for allegedly manipulating the reported results of the mid-stage study on simufilam.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback